Information Provided By: 
Fly News Breaks for June 28, 2016
ENDP
Jun 28, 2016 | 13:41 EDT
Mizuho analyst Irina Koffler said the issuance of a new patent to Endo by the USPTO relating to Vasostrict "negatively impacts" the short thesis on the stock, while also noting that she thinks it is likely true that Endo is exploring potential asset sales, as indicated in new media reports. The analyst added, however, that she does not expect anyone to buy the whole company this year. Mizuho has a Neutral rating and $16 price target on Endo shares.
News For ENDP From the Last 2 Days
There are no results for your query ENDP
